> ## Content Index
> Fetch the complete content index at: https://www.fdaweb.com/llms.txt
> Use this file to discover other available public pages before exploring further.

# FDA Launches Interactive PEPFAR Database
- URL: https://www.fdaweb.com/fda-launches-interactive-pepfar-database/
- Published: 2020-01-29T12:00:00.000Z
- Updated: 2026-09-14T16:00:30.000Z
- Author: David McFarland
- Tags: Drugs, #legacy-id-D5145956

FDA says it is launching an interactive database offering “a wealth of critical information” about antiretrovirals (ARVs) eligible for purchase under the President’s Emergency Plan for AIDS Relief (PEPFAR) program. The agency [says](https://www.fda.gov/news-events/press-announcements/fda-launches-mobile-friendly-database-information-life-saving-hiv-drugs-part-ongoing-mission-empower?ref=fdaweb.com) the list of ARVs eligible for purchase in the PEPFAR program has been publicly available on the FDA Web site for a long time. “By moving to an interactive, mobile-friendly [database](https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=pepfar.page&ref=fdaweb.com),” it says, “we are empowering the public and healthcare providers by enhancing the amount and availability of information and data provided on each drug. For the first time, healthcare providers, consumers, and procurers will be able to easily access the FDA-reviewed product labeling, which will provide additional important information to patients and healthcare providers such as the full prescribing information (package insert) that contains a summary of essential scientific information needed for safe and effective use of the drug.”

FDA says it has approved or tentatively approved 222 ARV applications for use in PEPFAR partner countries since 2004, of which 194 are still available for treatment today.